# BETAMETHASONE DIPROPIONATE
> **ANDA219348** · Abbreviated New Drug Application (Generic) · Sponsor: AUROBINDO PHARMA LTD · Approved 2026-01-26
## Drug
- **FDA Application Number:** ANDA219348
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** BETAMETHASONE DIPROPIONATE
- **Generic name:** BETAMETHASONE DIPROPIONATE
- **Active ingredients:** BETAMETHASONE DIPROPIONATE
- **Dosage form:** CREAM
- **Route:** TOPICAL
- **Marketing status:** Prescription
- **Sponsor:** AUROBINDO PHARMA LTD
- **Manufacturer:** Aurobindo Pharma Limited
- **First approval:** 2026-01-26
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=219348)
---
*AI Analytics · CC0 1.0*